Download presentation
Presentation is loading. Please wait.
Published byİbrahi̇m Akalın Modified over 5 years ago
1
Lack of protein prenylation promotes NLRP3 inflammasome assembly in human monocytes
Oliver P. Skinner, BSc, Julie Jurczyluk, BSc, Paul J. Baker, PhD, Seth L. Masters, PhD, Alicia G. Rios Wilks, BSc, Misaki S. Clearwater, BSc, Avril A.B. Robertson, PhD, MChem, GCHEd, Kate Schroder, PhD, Sam Mehr, MBBS, BMedSci, FRCPA, FRACP, Marcia A. Munoz, PhD, Michael J. Rogers, PhD Journal of Allergy and Clinical Immunology Volume 143, Issue 6, Pages e3 (June 2019) DOI: /j.jaci Copyright © 2019 The Authors Terms and Conditions
2
Fig 1 A-D, SIM pretreatment enhanced LPS-induced IL-1β release (Fig 1, A), ASC speck formation (Fig 1, B), caspase-1 activity (Fig 1, C), and IL-18 release (Fig 1, D), all of which were restored to control levels in the presence of GGOH. Data in Fig 1, D, are from 1 representative experiment of more than 4 (IL-1β) or 2 (IL-18) experiments. E, GGOH prevented SIM-induced accumulation of unprenylated Rab (uRabs) and unprenylated Rap1A (uRap1A) proteins. F, Doxycycline-inducible knockout of NLRP3, pyrin, or caspase-1 proteins in Cas9-expressing THP-1 cells. KO, Knockout. G, Lack of NLRP3 or CASP1, but not MEFV (pyrin), abolished LPS-induced IL-1β release and prevented the enhancing effect of SIM. H and I, MCC950 inhibited LPS-induced caspase-1 activity (Fig 1, H) and IL-1β release (Fig 1, I) and blocked the enhancing effect of SIM in THP-1 cells. J, After stimulation with LPS/nigericin, IL-1β release was increased in PBMCs from a patient with MKD compared with PBMCs from each unaffected parent, and MCC950 completely abolished IL-1β production in all PBMC cultures. K, SIM pretreatment enhanced formation of ASC specks and IL-1β release after Pam3CSK4 stimulation in THP-1 cells. Values represent either means ± SDs from 3 independent experiments (**P < .01, ***P < .001, and ****P < .0001) or are representative of at least 3 separate experiments. Journal of Allergy and Clinical Immunology , e3DOI: ( /j.jaci ) Copyright © 2019 The Authors Terms and Conditions
3
Fig E1 A and B, SIM treatment did not affect THP-1 cell viability (Trypan Blue exclusion; Fig E1, A) but caused a concentration-dependent accumulation of unprenylated Rab (uRabs) and Rap1A (uRap1A) GTPases (Fig E1, B). Endogenous 75-kDa biotinylated protein was used as a loading control. C, SIM treatment enhanced LPS-induced pyroptosis (propidium iodide [PI] uptake), and pyroptosis was restored to normal levels by means of GGOH addition and abolished by MCC950. D and E, Doxycycline-induced NLRP3 deletion abolished ASC speck formation (Fig E1, D) and caspase-1 activity (Fig E1, E) upon LPS stimulation (nigericin treatment was used as a positive control). F, CASP4 and CASP5 were not required for the enhancing effects of SIM on IL-1β release after LPS stimulation. Loss of caspase-4 was confirmed by using western blotting. G, Blocking [K+] efflux with 50 mmol/L extracellular [K+] abolished LPS-induced IL-1β release in the presence or absence of SIM. H, The reactive oxygen species scavenger butylated hydroxyanisole (BHA) prevented SIM-enhanced IL-1β release after LPS stimulation. I, MCC950 inhibited LPS-stimulated IL-1β release from cells pretreated with SIM or GGTI-298. **P < .01 and ****P < Values in all figures are means ± SDs of triplicate wells, with the exception of Fig E1, H, showing means of duplicate wells. All data shown are representative of 3 independent experiments. Journal of Allergy and Clinical Immunology , e3DOI: ( /j.jaci ) Copyright © 2019 The Authors Terms and Conditions
4
Fig E2 Pretreatment of THP-1 cells with SIM did not enhance mRNA or protein expression of inflammasome components/substrates. A, Quantitative PCR analysis of mRNA expression of genes encoding IL-1β, IL-18, NLRP3, pyrin (MEFV), ASC, and caspase-1 in control cells (black lines) or SIM-pretreated cells (red lines) for up to 6 hours after LPS stimulation. Values are means ± SDs from 3 independent experiments. B, Western blots showing protein levels of pro–IL-1β, NLRP3, pyrin, and pro–caspase-1 in control or SIM-pretreated cells for up to 4 hours after LPS stimulation. Zero hours represents control or SIM pretreatment before LPS stimulation; β-actin was used as a loading control. Blots are representative of 3 independent experiments. Journal of Allergy and Clinical Immunology , e3DOI: ( /j.jaci ) Copyright © 2019 The Authors Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.